Genetic Tech Ltd.-SP ADRGENE
13F holders, Q3 2024 (September 30)10holders +3
5new positions
2sold out
1famous investor
$0.77avg. 13F price*
At the end of Q3 2024, 10 institutions reported holding Genetic Tech Ltd.-SP ADR (GENE) in their 13F filings, up 3 from Q2 2024. 5 opened new positions and 2 sold out. The largest holders were Susquehanna International Group, LLP ($21K), Morgan Stanley ($15K) and BNP Paribas Financial Markets ($12K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Genetic Tech Ltd.-SP ADR
- CUSIP
- 37185R406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $19K |
| Exits | 2 | $210K |
All 13F filers, Q2 2024 → Q3 2024: 27,928 shares bought and 189,941 shares sold, net −162,013 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Susquehanna International Group, LLP | 0.00% | Reduce -64.3% | 27,617 | $21K |
| Morgan Stanley | 0.00% | Add +7.8% | 19,389 | $15K |
| BNP Paribas Financial Markets | 0.00% | Add +19.8% | 15,100 | $12K |
| Two Sigma Securities, LLC | 0.00% | New | 14,457 | $11K |
| UBS Group AG | 0.00% | New | 8,866 | $7K |
| Rhumbline Advisers | 0.00% | No change | 3,739 | $3K |
| Citadel Advisors | 0.00% | New | 682 | $510 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $310 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 18 | $13 |
| Ashton Thomas Securities, LLC | 0.00% | New | 5 | $4 |
"% of holder's portfolio" is GENE's weight in each manager's 13F, not the share of Genetic Tech Ltd.-SP ADR the manager owns.